PALO ALTO, Calif.--(BUSINESS WIRE)--Bayhill Therapeutics Inc., a clinical-stage biotechnology company developing innovative therapies for autoimmune diseases, has named Paul Westberg to the newly created position of Vice President of Business Development. Mr. Westberg will be responsible for developing strategic partnerships for some of Bayhill’s key therapeutic programs.
